Immunotherapy in Combination with Chemotherapy for Triple-Negative Breast Cancer
Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that lacks estrogen and progesterone receptors and does not overexpress the human epidermal growth factor receptor 2 (HER2). Previous treatment options for TNBC were limited to chemotherapy alone, resulting in a poor pati...
Na minha lista:
| Outros Autores: | , , |
|---|---|
| Formato: | Artículo |
| Idioma: | en_US |
| Publicado em: |
2023
|
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.2174/1389557523666230517152538 https://pubmed.ncbi.nlm.nih.gov/37198990/ |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|
Seja o primeiro a deixar um comentário!